Veterinary Point of Care Diagnostics Market Size: USD 7.66 Bn & 10.39% CAGR Growth | 2034
The veterinary point-of-care diagnostics market accounted for USD 2.85 billion in 2024 and is expected to reach around USD 7.66 billion by 2034, growing with a CAGR of 10.39% from 2025 to 2034. This market is growing due to increasing demand for rapid, on-site diagnostic solutions that enable early disease detection and timely treatment in animals.
The U.S. veterinary point of care diagnostics market size was valued at USD 1.0 billion in 2024 and is expected to reach around USD 2.8 billion by 2034, growing at a CAGR of 9.81% from 2025 to 2034.
North America dominates the veterinary point-of-care diagnostics market due to due to rising pet ownership rates, sophisticated veterinary facilities and rising animal healthcare expenditures. The area is home to several major market participants in ongoing technological developments and many veterinary clinics and hospitals using rapid diagnostic technologies. North Americas dominance is further reinforced by government programs promoting animal health and growing awareness of zoonotic diseases. Additionally, the rising acceptance of pet insurance motivates pet owners to spend money on diagnostic and preventative care. Additionally, the growing need to manage livestock diseases especially in the U. S. S. In rural and agricultural settings Canada is spearheading the adoption of portable AI-powered diagnostic tools.
Asia Pacific is expected to grow at the fastest rate in veterinary point-of-care diagnostics during the forecast period driven by growing livestock production, expanding pet adoption and enhancing veterinary healthcare systems. The need for POC testing is being fueled by rising investments in veterinary diagnostics as well as increased awareness of animal health. Veterinary clinic expansion and the use of portable reasonably priced diagnostic equipment are driving market expansion in nations like China India and Japan. Further driving the need for quick veterinary diagnostics are government programs to improve food safety regulations and manage livestock diseases. The market is expanding as a result of rising pet healthcare expenditures brought on by urbanization and disposable income in developing countries.
Europe is currently experiencing the most rapid growth in the veterinary point-of-care diagnostics market, reinforced by strict laws pertaining to animal health and a veterinary healthcare system that has been in place for a long time. Rapid diagnostic solutions are becoming more and more in demand in the region particularly for the management of livestock diseases. The market's growth potential is being further enhanced by technological developments and partnerships between diagnostic companies and veterinary research institutions. Advanced diagnostic tools are also being adopted more widely as a result of European nations emphasis on biosecurity and sustainable livestock farming. To improve disease management and treatment results veterinary clinics are also encouraged to invest in quick and precise diagnostic tools by the growing incidence of zoonotic diseases and stringent animal welfare laws.
By facilitating quicker more precise and effective disease detection developments in machine learning and data-driven technologies are revolutionizing veterinary point-of-care diagnostics. Veterinarians can analyze complex data spot trends and make well-informed decisions instantly with the help of these clever solutions. Predictive analytics digital pathology tools and automated image recognition are making diagnostic procedures more dependable, cutting down on turnaround time and enhancing patient care. Additionally, the incorporation of these technologies reduces human error, improves early disease detection, and facilitates precision treatment plans for livestock and pets.
This transformation is being driven by several companies. To provide quick in-clinic diagnostics Zoetis has added applications for dermatology urine sediment analysis and equine fecal egg count to its Vetscan Imagyst platform. DecisionIQ is now a part of IDEXX Laboratories VetConnect PLUS software which helps identify diseases early by identifying subtle disease indicators from standard diagnostic tests. A division of Mars Veterinary Health Antech Diagnostics has created digital cytology services that quickly interpret pathology samples using machine learning. These developments demonstrate how state-of-the-art technology is raising the precision and effectiveness of veterinary diagnostics.
Increased awareness of animal health and technological advancements are driving the rapid growth of the veterinary point-of-care diagnostics market. Fast on-site testing is made possible by these diagnostics which speeds up the process of deciding on treatments for both pets and livestock. Big players like IDEXX Laboratories and Zoetis are spending money on innovations to increase accuracy and efficiency. Despite issues like staffing shortages and inflation, there is still a growing need for rapid diagnostics. The need for early disease detection, rising pet ownership, and rising animal care expenses are the main drivers of market growth.
| Report Coverage | Details |
| Market Size in 2025 | USD 3.15 Billion |
| Market Size by 2034 | USD 7.66 Billion |
| Growth Rate From 2025 to 2034 | CAGR of 10.39% |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Segments Covered | Animal Type, Product, Testing Category, Indication, Sample Type, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
| Key Companies Profiled | IDEXX Laboratories, Inc.; Zoetis; Heska Corporation (Antech); Virbac; Thermo Fisher Scientific, Inc.; Mindray; Woodley Equipment Company Ltd; FUJIFILM Corporation; Getein Biotech |
Drivers
Rapid Disease Detection Needs
A quicker diagnosis enables early treatment which lowers mortality rates and avoids complications. The SNAP tests from IDEXX Laboratories eliminate the need for lab-based testing by offering rapid results for infectious diseases like parvovirus and feline leukemia. The Vetscan like from Zoetis, includes portable analyzers that provide electrolyte and blood chemistry testing in real-time improving decision-making in urgent situations. The Element I + immunodiagnostic Analyzer from Heska Corporation allows veterinarians to quickly test for infectious thyroid and cortisol disorders. These quick diagnostic tools are crucial in situations where treatment delays could be fatal. Rapid and accurate POC diagnostics are becoming essential in veterinary care as the incidence of infectious and zoonotic diseases increases.
Rise in Veterinary Expenditure
Spending more on diagnostics is opening access to more sophisticated solutions the multinational animal health corporation Virbac makes investments in cutting-edge veterinary diagnostics equipment to promote early disease detection and lower the expense of ongoing care. By enabling noninvasive and instantaneous imaging FUJIFILM Healthcare portable ultrasound devices enhance diagnostic capabilities in both pets and livestock. In keeping with the growing focus on disease prevention. Thermo Fisher Scientific has added PCR-based tests for early disease detection in farm animals to its portfolio of veterinary diagnostics. The demand for veterinary diagnostics is rising as a result of pet owners and livestock farmers being more prepared than ever to pay for regular checkups, immunizations, and urgent illnesses. Advanced veterinary healthcare solutions are becoming more and more popular due to the global trend of premium pet care and growing awareness of early disease intervention.
Restraints
Accuracy & Reliability Concerns
Some POC diagnostic tools are less sensitive and specific than centralized laboratory tests even with recent technological advancements. Misdiagnosis resulting from inconsistent or inaccurate results can postpone appropriate treatment. Test reliability can also be impacted by outside variables like environmental conditions, improper handling, and contaminated samples. Veterinarians frequently flavor laboratory-based testing techniques that go through stringent validation procedures to guarantee higher accuracy, it will take better quality control procedures and ongoing advancements in POC diagnostic technology to allay these worries.
Accuracy & Reliability Concerns
Compared to centralized lab tests some POC diagnostic devices continue to have problems with accuracy and consistency, POC technology can lose credibility if false positives or false negatives result in inappropriate treatment regimens. Test results can be impacted by variables like environmental conditions reagent variability and mistakes made when handling samples. Because lab-based diagnostics are subjected to more stringent validation and quality control veterinarians frequently favor them. For POC tests to be widely used their sensitivity and specificity must be increased.
Opportunities
Growth of Home-Based and Wearable Pet Diagnostics
Home-based diagnostics tools are becoming more and more popular as pet wellness and preventive care gain popularity. Businesses that provide cutting-edge solutions for early disease detection include FitBark (wearable pet health monitors) and Basepaws (pet genetic testing). To enable pet owners to keep an eye on their pets' blood sugar levels kidney function and other critical indicators, Zoetis has made investments in at-home testing kits. Pets can have continuous health tracking with wearable health monitoring devices like PetPace and Whistle which eliminates the need for frequent veterinary checkups. Since home-based diagnostics are now more widely available due to the growth of e-commerce and direct-to-consumer sales a new market niche for veterinary POC diagnostics is being created.
Expansion of Livestock Disease Management Programs
Preventing livestock diseases is becoming a greater priority for governments and international organizations to increase food security and economic stability. Rapid diagnostics kits are being developed by organizations such as Merck Animal Health and Thermo Fisher Scientific to track and manage diseases in pigs' poultry and cattle. Farmers are investing more in disease surveillance tools to ensure compliance and safeguard the health of their herds considering the words tighter food safety regulations. The need for POC testing in the livestock industry is also being driven using digital herd management systems that incorporate diagnostic data. Investments in rapid diagnostics for illnesses like African swine fever avian influenza and bovine tuberculosis are anticipated to increase because of this trend.
Companion animals segment dominated the veterinary point-of-care diagnostics market with the largest share in 2024 driven by rising healthcare costs and pet ownership. When it comes to advanced diagnostics for conditions like diabetes, kidney disease, and heart issues pet owners are more proactive. Because they yield quick results and lessen stress for both pets and their owners, in-clinic diagnostic solutions are becoming more and more popular. Furthermore, more people can afford sophisticated diagnostic tools thanks to the growth of pet insurance. Veterinarians can now detect and treat illnesses more effectively thanks to biosensor technologies and AI-powered analyzers that are further improving diagnostic accuracy.
Livestock animal segment is expected to grow at the fastest rate in the market motivated by growing worries about disease outbreaks food safety and international livestock trade laws. To ensure healthier livestock and lower financial losses farmers and veterinarians are investing in cutting-edge diagnostic equipment to identify diseases early. In rural and agricultural settings portable POC devices and molecular testing kits are becoming indispensable for enhancing herd management and facilitating speedier responses to outbreaks. Government programs supporting the productivity and well-being of animals are also driving market expansion.
Consumables, reagents, and kits segment dominated the veterinary point-of-care diagnostics market with the largest share in 2024 as a result of rising healthcare costs and pet ownership. In-clinic testing is in high demand as pet owners look for quick precise diagnoses for ailments like diabetes and kidney disease. Technological developments in biosensors and AI-powered analyzers further improve diagnostic effectiveness
In 2024 September Zomedica Corp. introduced the eACTH assay for its TRUFORMA Platform which makes it possible to diagnose Cushing's disease in horses quickly. Chengdu Seamaty Technology Co. in August 2024. Ltd. improved the diagnostics for cats and dogs by introducing four veterinary analyzers including the VG2 Vet Blood Gas Electrolyte Immunoassay Analyzer
Instruments and devices segment is expected to grow at the fastest rate in the market due to growing disease outbreaks and food safety concerns. POC diagnostics are being used by farmers to improve herd health, minimize financial losses, and detect diseases early. To improve disease management in rural areas portable testing kits and molecular diagnostics are being utilized more and more.
Parasitology segment dominated the veterinary point-of-care diagnostics market with the largest share in 2024 because parasitic infections are very common in livestock and pets. In veterinary clinics and on farms quick diagnostic tools are frequently used to identify parasites such as intestinal worms' fleas and ticks. The need for rapid and precise testing as well as increased knowledge of parasite control among farmers and pet owners is fueling market expansion.
Hematology segment is expected to grow at the fastest rate in the market driven by the need for early disease detection and the development of blood analysis technology. Hematology tests are crucial for both routine examinations and emergency care because they aid in the diagnosis of anemia infections and immune disorders in animals. Blood test accuracy and efficiency have increased even more with the development of AI-driven hematology analyzers.
Blood/plasma/serum segment dominated the veterinary point-of-care diagnostics market with the largest share in 2024 because of the vital role it plays in identifying metabolic disorders infections and organ failure. These tests are frequently used to diagnose diseases in companion and livestock animals such as diabetes liver disease and anemia. This segment is the most trusted for veterinary diagnostics due to its high accuracy quick results and expanding use of sophisticated analyzers.
Further driving demand for blood-based testing is the rise in routine health examinations and veterinary visits.
Urine segment is expected to grow at the fastest rate in the market because it is noninvasive and efficient in identifying diabetes kidney diseases and UTIs. Dipstick tests and portable urine analyzers are becoming more and more popular in veterinary clinics for easy and rapid diagnosis. This market is growing quickly due in part to the increased need for early disease detection in livestock and the growing awareness of preventive pet healthcare. Additionally, improvements in automated urine analysis technology are increasing accuracy and efficiency which is propelling the market's expansion.
Infectious disease segment dominated the veterinary point-of-care diagnostics market with the largest share in 2024 because infections caused by bacteria viruses and parasites are very common in animals. To stop epidemics and guarantee prompt treatment diseases like bovine tuberculosis canine parvovirus and feline leukemia need to be identified quickly and accurately. The dominance of this market is still being driven by rising awareness among pet owners and livestock farmers as well as the need for quick diagnostic answers. Testing for infectious diseases is now an essential part of veterinary care due to improvements in detection accuracy brought about by developments in immunoassay and molecular diagnostic technologies.
General ailments segment is expected to grow at the fastest rate in the market driven by the growing emphasis on early disease detection and regular health examinations. The rising prevalence of diseases like obesity, diabetes, allergies and digestive issues in pets and livestock is driving up demand for diagnostics. Growing awareness of preventive healthcare, easier access to veterinary care and an increase in pet ownership are all contributions to this market's expansion. Furthermore, general health testing in veterinary clinics is becoming more accessible and efficient with the integration of AI and automated diagnostic tools.
The Veterinary hospitals & clinics segment dominated the veterinary point-of-care diagnostics market with the largest share in 2024 because of the large number of patients visiting and the availability of cutting-edge diagnostic equipment. These clinics handle a variety of diagnostic tests including imaging blood work and infectious disease screening and act as the main point of care for pets and livestock, in clinic diagnostics are in high demand due to the expanding pet insurance market and rising animal healthcare costs. Veterinarians also depend on these tests because they provide results instantly allowing for quicker treatment decisions and better patient outcomes.
Point-of-care diagnostics segment is expected to grow at the fastest rate in the market because demand for quick on-site testing solutions is growing. Veterinarians can make quick diagnoses without sending samples to outside labs thanks to portable analyzers handheld devices and in-clinic diagnostic kits. This improves the effectiveness of treatment; cuts expense and shortens wait times. The growth of POC testing is being further fueled by the growing availability of easy-to-use AI-integrated diagnostics tools that make it more accessible for smaller veterinary practices and even pet owners at home.
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the Veterinary Point of Care Diagnostics Market
By Animal Type
By Product
By Testing Category
By Sample Type
By Indication
By End-use
By Regional
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers